Likewise, recombinant FGF21 also demonstrates a dramatic effect in normalizing plasma glucose levels, improving insulin sensitivity, reducing plasma TG and cholesterol levels in various diabetic animal models and diabetic rhesus monkeys, exhibiting an attractive profile as a potential novel therapy for treating metabolic disorders (35, 38–42). The gene discussed is FGF21; the disease is Other metabolic disease.